Globe Life Stock Surges 7.5%, With A 7-Day Winning Spree
Globe Life (GL) stock hit day 7 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 7.5% return. The company has gained about $806 Mil in value over the last 7 days, with its current market capitalization at about $12 Bil. The stock remains 27.2% above its value at the end of 2024. This compares with year-to-date returns of 15.9% for the S&P 500.
Globe Life’s recent streak was fueled by TD Cowen naming it a ‘Best Idea for 2026’ with a $199 target, citing robust growth in an underserved market. This analyst conviction, alongside resolved regulatory inquiries and attractive valuation multiples, ignited investor confidence.
What is the point? Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades. Our take: There are a few things to fear in GL stock given its overall Weak operating performance and financial condition. Hence, despite its Low valuation, this makes the stock look Risky (see Buy or Sell GL).
For quick background, GL provides life and supplemental health insurance products, annuities, and investment services through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Comparing GL Stock Returns With The S&P 500
The following table summarizes the return for GL stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | GL | S&P 500 |
|---|---|---|
| 1D | 0.9% | -0.2% |
| 7D (Current Streak) | 7.5% | -0.6% |
| 1M (21D) | 5.6% | 1.2% |
| 3M (63D) | 0.0% | 3.2% |
| YTD 2025 | 27.2% | 15.9% |
| 2024 | -7.5% | 23.3% |
| 2023 | 1.8% | 24.2% |
| 2022 | 29.7% | -19.4% |
However, big gains can follow sharp reversals – but how has GL behaved after prior drops? See GL Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 105 S&P constituents with 3 days or more of consecutive gains and 41 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 31 | 31 |
| 4D | 41 | 4 |
| 5D | 24 | 4 |
| 6D | 3 | 2 |
| 7D or more | 6 | 0 |
| Total >=3 D | 105 | 41 |
Key Financials for Globe Life (GL)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $5.4 Bil | $5.8 Bil |
| EBT | $1.2 Bil | $1.3 Bil |
| Net Income | $970.8 Mil | $1.1 Bil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ2 | 2025 FQ3 |
|---|---|---|
| Revenues | $1.5 Bil | $1.5 Bil |
| EBT | $313.3 Mil | $477.1 Mil |
| Net Income | $252.7 Mil | $387.8 Mil |
While GL stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.